Mountain West AETC

University of Washington

Harborview Medical Center
Mail Stop: 359932, 325 Ninth Avenue
Seattle, WA 98104
United States

(206) 543-2704

Regional Scope

The Mountain West AETC serves Alaska, Colorado, Idaho, Montana, Oregon, North and South Dakota, Utah, Washington, and Wyoming through its central office and local partners.


For HIV training, technical assistance, and/or capacity building assistance anywhere in the Mountain West  AETC region, contact [email protected].  

Principal Investigator
Program Director
Phone: (206) 221-4943
Senior Computing Specialist
Regional Program Manager
Telehealth Manager
Phone: (206) 685-9625
Program Support Specialist
Medical Program Director
Practice Transformation Program Coordinator
Washington State Training Coordinator
Phone: (206) 543-3319
Corrections Program Director
Central and Eastern Washington Coordinator
MWAETC HIV ECHO Director/Trainer

Resources: 74

Title Publish Date Sort ascending Review Date
HIV PrEP: Future of PrEP
HIV & The Treatment of Depression
HIV Pre-Exposure Prophylaxis (PrEP) Expansion of Pharmacy-Delivered PrEP
Vaccine Update: COVID-19 and RSV
Fentanyl Updates
Immune Reconstitution Syndrome, 2023-Part 2
Buprenorphine for Opioid Use Disorder
Screening and Treatment of HPV Lesions to Reduce Anal Cancer: ANCHOR Results and Implications
Addressing the Increased Risk of Lung Cancer in People with HIV
Updates to Testing and Prophylaxis for Infants with HIV Exposure
Risk of HIV Transmission with Low Levels of Viremia
Clinical Reference Tools for Sexually Transmitted Infections (STI) - Oregon
Hepatitis B Prevention: New Vaccines and the Boundaries of HBV Protection
Management of HCV and HIV Coinfection
HIV Drug Resistance Testing Basics
PrEP for Transgender Patients Update
Certification Resources for Health Care Professionals
Recent Trials of Second-Line ART: Lessons Learned & Applications to Clinical Practice
Health Inequities and HIV Vulnerability
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
Cardiovascular Risks of Antiretroviral Therapy
Pneumocystis Pneumonia: Prevention & Treatment
Expedited Partner Therapy (EPT) Fact Sheet for Providers
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV
PrEP for PWID: Challenges and Opportunities
Fentanyl: A Hidden Epidemic
Pneumocystis Pneumonia: Part 1
Expedited Partner Therapy in 2022: Updated Guidance and Practical Realities
Treatment for STIs: A Guide for Medical Providers
PrEP for HIV Prevention: The 4-1-1 on 2-1-1
Unhealthy Alcohol Use Among Persons with HIV: A Modifiable Barrier to Optimal Management of HIV and its Comorbidities
Challenging Structural Racism in Medicine: Intro to Key Concepts of Critical Race Theory
“Microdosing” Buprenorphine Inductions
PrEP for Prevention of HIV in the U.S., 2021 Update
ART Update: New Guidelines & Medications
Fentanyl and Other High Potency Synthetic Opioids
Revisiting the Invisible Latino HIV Crisis: Examining Progress and Identifying Remaining Gaps in the National Response
Using HIV-ASSIST to Guide ART Decision-Making
Dapivirine Ring for HIV PrEP
Microaggressions in Healthcare: How to Respond
2021 STI Treatment Guidelines Update
Cryptococcosis in People with HIV: Updated Guidelines on Prevention & Treatment
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Fall Risk Evaluation & Management
“IM” Thinking About Using Long Acting Injectables
Treating Hepatitis C Among People who Use Drugs
Updates to the HHS Adult and Adolescent HIV Treatment Guidelines
Operationalizing Use of Long-Acting Injectable ART
Clinically Relevant Drug Interactions with Direct Acting Antivirals (DAAs)
Updates in TB Preventive Therapy Guidelines
Medications for Methamphetamine Use Disorder
Hepatitis C Treatment Update
Isolated Hepatitis B Core Antibody in People with HIV Infection
What will PrEP Implementation Look Like Post-COVID?
Prevention and Treatment of Hepatitis C Infection among People who Use Drugs
Microaggressions in Healthcare: Patient Experiences
Diabetes Medications for Type 2 Diabetes with Focus on HIV: Parts 1 & 2
Suicide and Overdose among People with HIV during the COVID-19 Pandemic: Updates and Opportunities for Mitigation
Pain Management in Individuals with Substance Use Disorders
Primary Care Considerations for Patients Using Methamphetamines
Understanding Frailty
Telemedicine and Opioid Use Disorder (OUD) Part 2: Clinical Tips
Cabotegravir plus Rilpivirine (Cabenuva): Extended Release Injectable Suspension
STIs and PrEP for People Who Inject Drugs
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV
Hepatitis B Immunity in HIV: Case Vignette
Does this Patient Need PEP?
Telemedicine and Opioid Use Disorder: Regulatory Changes and Evidence
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region
Telemedicine for People with HIV
HIV Non-Occupational Post-Exposure Prophylaxis (nPEP) and Processes of Patient Care
Implementing Telemedicine Webinar Series
Stigma and Addiction Training Slides
HIV Medication Chart Pad